Why the study?
The COVID-19 pandemic disrupted cardiovascular care delivery, but comprehensive evaluations of diabetes-AMI outcomes across diverse sociodemographics remain limited.
How did the COVID-19 pandemic and sociodemographic factors affect AMI discharges and in-hospital mortality among adults with diabetes?
Population
Adults (≥18 years) hospitalized with concurrent diabetes mellitus and AMI in California
Comparison
Outcomes across temporal trends (2016-2022) and sociodemographic groups including age, race/ethnicity, insurance, and geography
Design
Population-based retrospective cohort analysis
Key result
The COVID-19 pandemic increased AMI discharges by 34.8-46.5% and peaked in-hospital mortality by 24.4% among hospitalized adults with diabetes in California.
Authors
Loading...
May necessitate enhanced diabetic AMI monitoring in future crises; leaves open mechanisms and equity-targeted interventions.
Cohort
Yes
How did the COVID-19 pandemic and sociodemographic factors affect AMI discharges and in-hospital mortality among adults with diabetes?
The COVID-19 pandemic significantly increased AMI admissions and in-hospital mortality among diabetic patients in California, exposing profound sociodemographic disparities across age, race, geography, and insurance status.
RATNASIRI et al. (2026) conducted a cohort in Acute myocardial infarction with concurrent diabetes mellitus. COVID-19 pandemic vs. Pre-pandemic period was evaluated on AMI discharges and in-hospital mortality. The COVID-19 pandemic increased AMI discharges by 34.8-46.5% and peaked in-hospital mortality by 24.4% among hospitalized adults with diabetes in California.